Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
Articles, Neurobiology of Disease

Genetic Variants of Nogo-66 Receptor with Possible Association to Schizophrenia Block Myelin Inhibition of Axon Growth

Stéphane Budel, Thihan Padukkavidana, Betty P. Liu, Zeny Feng, Fenghua Hu, Sam Johnson, Juha Lauren, James H. Park, Aaron W. McGee, Ji Liao, Althea Stillman, Ji-Eun Kim, Bao-Zhu Yang, Stefano Sodi, Joel Gelernter, Hongyu Zhao, Fuki Hisama, Amy F. T. Arnsten and Stephen M. Strittmatter
Journal of Neuroscience 3 December 2008, 28 (49) 13161-13172; DOI: https://doi.org/10.1523/JNEUROSCI.3828-08.2008
Stéphane Budel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thihan Padukkavidana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betty P. Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zeny Feng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fenghua Hu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sam Johnson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Juha Lauren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James H. Park
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron W. McGee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji Liao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Althea Stillman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji-Eun Kim
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bao-Zhu Yang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefano Sodi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joel Gelernter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongyu Zhao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fuki Hisama
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy F. T. Arnsten
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen M. Strittmatter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Figure 4.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

The R377Q and R377W-NgR1 variants are dominant-negative disruptors of myelin signaling. A, Chick E7 retinal neurons were cultured with or without herpes simplex virus directing the expression of WT-NgR, R377Q-NgR1, or R377W-NgR1 as indicated. The cultures were exposed to 100 nm GST (glutathione S-transferase)-Nogo-66, for 30 min, and then fixed and stained with phalloidin for F-actin and with anti-NgR1 antibody. Note that the viruses drive the expression of NgR1 protein. WT-NgR1 allows growth cones to collapse in response to Nogo-66, but R-377Q-NgR1 does not. B, The fraction of collapsed E7 retinal growth cones expressing WT-NgR1 is significantly greater than that for growth cones expressing GFP after exposure to 100 nm Nogo-66 (*p < 0.05, one-way ANOVA). C, Neurite outgrowth over 16 h from E20 rat DRG was assessed on a monolayer of control or MAG-expressing CHO cells after infection of neurons with virus expressing GFP, WT-NgR, R377Q-NgR1, or R377W-NgR. Neurons are visualized with anti-βIII-tubulin immunohistology. D, Mean neurite outgrowth from neurons expressing WT-NgR1 is significantly decreased on MAG cells relative to control monolayers (*p < 0.05, one-way ANOVA). Outgrowth from neurons expressing variant NgR1 is not reduced by MAG. E, The percentage of collapsed E13 chick DRG growth cones expressing the indicated proteins is reported from cultures similar to those in A. The values with R377Q-NgR1 and R377W-NgR1 virus are significantly different from those with control GFP virus (*p < 0.05, one-way ANOVA). F, Growth cone collapse of E13 chick DRG growth cones in the presence of 100 nm Nogo-66, 100 nm MAG-Fc, 3 μg/ml myelin protein, or 10 nm Sema3A. Collapse was assessed without peptide, with 1 μm WT peptide, with 1 μm R377Q peptide, or with 1 μm R377W peptide. Note that the R377W peptide suppresses collapse by Nogo-66, MAG, and myelin but not by Sema3A. Values with the variant NgR1 peptides are significantly different from those with the WT NgR1 peptide (*p < 0.05, one-way ANOVA). G, E13 chick DRG growth cone collapse in presence of 100 nm MAG-Fc and various concentrations of R377W peptide. All data are mean ± SEM from n = 3–7 experiments.

  View article

In this issue

The Journal of Neuroscience: 43 (5)
Journal of Neuroscience
Vol. 43, Issue 5
1 Feb 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Masthead (PDF)
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Figure 4.
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Figure 4.
Journal of Neuroscience Dec 1969,

Citation Manager Formats

Respond to this article
Request Permissions
Share
Figure 4.
Journal of Neuroscience Dec 1969,
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Related Articles

Cited By...

  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.